FDA Advisory Panel Votes 15 To 0 In Favor Of Approving Envoy Medical's Esteem R Fully Implantable Hearing Restoration System
Envoy Medical, a Minnesota corporation, has developed the first Fully Implantable Hearing Restoration System known as the Esteem® . On December 18th, an Advisory Panel of independent ENT experts unanimously recommended that the FDA approve the Esteem® . Patrick Spearman, Envoy Medical's Chief Executive Officer, was quoted as saying "This is great news for all sensorineural hearing loss sufferers. Envoy has been able to accomplish with the Esteem® what hearing aids set out to do but were unable to. Our Esteem® allows recipients the opportunity to hear naturally and restore their lives back to normal." In the clinical trial, patients averaged an 11 decibel improvement in Speech Reception Threshold (SRT) scores beyond their hearing aids.
Music therapy can assist in the speech acquisition process in toddlers who have undergone cochlear implantation, as revealed in a new study by Dr. Dikla Kerem of the University of Haifa. The study was carried out in Israel as a doctoral thesis for Aalborg University in Denmark (supervised by Prof. Tony Wigram) and presented at a "Brain, Therapy and Crafts" conference at the University of Haifa. Some infants who are born with impaired hearing and who cannot benefit from hearing aids are likely to gain 90% normal hearing ability by undergoing a cochlear implantation procedure. Following the operation, however, the child - who never heard before - undergoes a long rehabilitation process before he or she can begin to speak.
Loss of spiral ganglion neurons or hair cells in the inner ear is the leading cause of congenital and acquired hearing impairment. Researchers at the University of California, San Diego, School of Medicine and the National Institutes of Health found that Sox2, a protein that regulates stem cell formation, is involved in spiral ganglion neuron development. The study was published in the January 13 issue of the Journal of Neuroscience. "These findings may provide the first step toward regenerating spiral ganglion neurons, the nerve cells that send sound representations to the brain, " said Alain Dabdoub, PhD, co-investigator and assistant professor of surgery with the division of otolaryngology at the UC San Diego School of Medicine.
A new study into hearing has uncovered the secret of our extraordinary ability to perceive a range of sounds - from a pin dropping to the roar of a jet engine - and could lead to a better understanding of deafness and hearing loss. With further research, it is hoped that we may soon be closer to understanding mechanisms behind deafness, enabling improved methods aimed at repairing hearing loss due to damage or genetic defects. The findings also shed light on other sensory systems, such as smell and vision. Funded by the Wellcome Trust, Deafness Research UK and the Royal Society, Dr Walter Marcotti, of Sheffield University's Department of Biomedical Science, has discovered how a particular calcium sensor present in highly specialised sensory cells allows us to hear with such remarkable sensitivity across a wide range of sound intensities.
A gene associated with a rare form of progressive deafness in males has been identified by an international team of researchers funded by the National Institute on Deafness and Other Communication Disorders. The gene, PRPS1, appears to be crucial in inner ear development and maintenance. The findings are published in the Dec. 17 early online issue of the American Journal of Human Genetics. "This discovery offers exciting therapeutic implications, " said James F. Battey, Jr., M.D., Ph.D., director of the NIDCD. "Not only does it give scientists a way to develop a targeted treatment for hearing loss in boys with this disorder, it may also open doors to the treatment of other types of deafness, including some forms of acquired hearing loss.
Pioneering new research funded by RNID has revealed hope for the early treatment of tinnitus. The study, led by researchers at the University of Western Australia, has revealed that for a certain period, spontaneous nerve activity in the brain previously shown to be associated with some types of tinnitus is dependent on signals from the ear. So temporarily reducing the signals sent from the ear to the brain opens up the possibility of treating tinnitus early after onset. Tinnitus can be a distressing and debilitating condition that affects most people at some point. Currently, around one in 100 people experience serious problems with long-term tinnitus.